National Center for Complementary & Integrative Health; Notice of Meeting, 18949-18950 [2024-05540]
Download as PDF
Federal Register / Vol. 89, No. 52 / Friday, March 15, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required) and Investigator
Initiated Extended Clinical Trial (R01
Clinical Trial Required).
Date: April 12, 2024.
Time: 9:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G34,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Vishakha Sharma, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G34, Rockville, MD
20852, 301–761–7036, vishakha.sharma@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05503 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:17 Mar 14, 2024
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Technologies for
Health Disparities RFA–EB–21–001 Review.
Date: May 31, 2024.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, Suite 920, 6707 Democracy
Blvd., Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Yoon-Young Jang, MD,
Ph.D., Scientific Review Officer, National
Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health,
6707 Democracy Blvd., Bethesda, MD 20892,
(301) 451–3397, yoon-young.jang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: March 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05541 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Complementary and
Integrative Health. The meeting will be
Jkt 262001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
18949
open to the public as indicated below,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session can be accessed at the following
NIH Videocast URL link https://
videocast.nih.gov.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: May 17, 2024.
Closed: 9:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 31
Center Drive, Building 31C/6th Floor,
Conference Room A&B, Bethesda, MD 20892.
Open: 11:10 a.m. to 4:00 p.m.
Agenda: Reports and Updates about Recent
and Ongoing NCCIH Led or Involved
Activities by NCCIH staff and its Director.
Place: National Institutes of Health, 31
Center Drive, Building 31C/6th Floor,
Conference Room A&B, Bethesda, MD 20892.
Contact Person: Martina Schmidt, Ph.D.,
Director, Division of Extramural Activities,
National Center for Complementary &
Integrative Health, NIH, 6707 Democracy
Blvd., Suite 401, Bethesda, MD 20892, (301)
594–3456, schmidma@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should be less than
700 words in length, and should include the
name, email address, telephone number and
when applicable, the business or professional
affiliation of the interested person. Any
member of the public may submit written
comments no later than May 3rd, 2024 (14
days before the council meeting).
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
E:\FR\FM\15MRN1.SGM
15MRN1
18950
Federal Register / Vol. 89, No. 52 / Friday, March 15, 2024 / Notices
www.nccih.nih.gov/news/events/advisorycouncil-87th-meeting, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: March 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05540 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
Member Conflict: Disease, Cognitive
Aging, and Related Dementias April 2,
2024, 1:00 p.m. to April 2, 2024, 7:00
p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
March 11, 2024, 89 FR 17494, Doc
2024–05079.
This meeting is being amended to
change the panel name to Member
Conflict: Alzheimer’s Disease, Cognitive
Aging, and Related Dementias. The
meeting is closed to the public in
accordance with provisions set forth in
sections 552b(c)(4) and 552b(c)(6).
Dated: March 12, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05599 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Sep<11>2014
18:17 Mar 14, 2024
Jkt 262001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Anti-Infective Therapeutics.
Date: April 10–11, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza National Airport, 1480
Crystal Drive, Arlington, VA 22202.
Contact Person: Marcus Ferrone,
PHARMD, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–2371, marcus.ferrone@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
HEAL KIDS Acute Pain Program.
Date: April 10, 2024.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, (301) 496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular and Electrophysiological
Aspects of Psychiatric and Neurologic
Disorders in Humans and Animal Models.
Date: April 11, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, (301) 435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epidemiology and Population
Health.
Date: April 11, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rebecca I. Tinker, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 435–0637, tinkerri@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Transmission of VectorBorne and Zoonotic Diseases.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Date: April 11, 2024.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20894, (301) 435–4057, bidyottam.mittra@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 11, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05482 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
Fellowships: Infectious Diseases and
Immunology A Study Section, April 3,
2024, 10:00 a.m. to April 4, 2024, 7:00
p.m., National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
March 8, 2024, 89 FR 16776, Doc 2024–
04932.
This notice is being amended to
change the meeting start time from
10:00 a.m. to 9:00 a.m. The meeting is
closed to the public in accordance with
provisions set forth in sections
552b(c)(4) and 552b(c)(6).
Dated: March 11, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–05483 Filed 3–14–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
E:\FR\FM\15MRN1.SGM
15MRN1
Agencies
[Federal Register Volume 89, Number 52 (Friday, March 15, 2024)]
[Notices]
[Pages 18949-18950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05540]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Integrative Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Complementary and Integrative Health. The meeting will be
open to the public as indicated below, with attendance limited to space
available. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The open session can be accessed at the
following NIH Videocast URL link https://videocast.nih.gov.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Integrative Health.
Date: May 17, 2024.
Closed: 9:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 31 Center Drive, Building
31C/6th Floor, Conference Room A&B, Bethesda, MD 20892.
Open: 11:10 a.m. to 4:00 p.m.
Agenda: Reports and Updates about Recent and Ongoing NCCIH Led
or Involved Activities by NCCIH staff and its Director.
Place: National Institutes of Health, 31 Center Drive, Building
31C/6th Floor, Conference Room A&B, Bethesda, MD 20892.
Contact Person: Martina Schmidt, Ph.D., Director, Division of
Extramural Activities, National Center for Complementary &
Integrative Health, NIH, 6707 Democracy Blvd., Suite 401, Bethesda,
MD 20892, (301) 594-3456, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should be less than 700 words in
length, and should include the name, email address, telephone number
and when applicable, the business or professional affiliation of the
interested person. Any member of the public may submit written
comments no later than May 3rd, 2024 (14 days before the council
meeting).
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit. Information is also available on the Institute's/
Center's home page: https://
[[Page 18950]]
www.nccih.nih.gov/news/events/advisory-council-87th-meeting, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.213,
Research and Training in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: March 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-05540 Filed 3-14-24; 8:45 am]
BILLING CODE 4140-01-P